ES8301990A1 - Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos. - Google Patents

Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.

Info

Publication number
ES8301990A1
ES8301990A1 ES506284A ES506284A ES8301990A1 ES 8301990 A1 ES8301990 A1 ES 8301990A1 ES 506284 A ES506284 A ES 506284A ES 506284 A ES506284 A ES 506284A ES 8301990 A1 ES8301990 A1 ES 8301990A1
Authority
ES
Spain
Prior art keywords
carbamimidoyl
carbadethiapen
aryl
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506284A
Other languages
English (en)
Other versions
ES506284A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES506284A0 publication Critical patent/ES506284A0/es
Publication of ES8301990A1 publication Critical patent/ES8301990A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ACIDOS 1-CARBADESTIAPEN-2-EM- 3-CARBOXILICOS 2- Y 6-SUSTITUIDOS Y DE SALES, ESTERES Y AMIDAS FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R , R Y R PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA HSR , EN LAS QUE X ES UN GRUPO SALIENTE; R ES UN GRUPO PROTECTOR Y R , R Y R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UNA BASE, A UNA TEMPERATURA ENTRE -40<025>C Y 25<025>C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIBIOTICOS.
ES506284A 1980-10-17 1981-10-15 Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos. Expired ES8301990A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19785680A 1980-10-17 1980-10-17

Publications (2)

Publication Number Publication Date
ES506284A0 ES506284A0 (es) 1983-01-01
ES8301990A1 true ES8301990A1 (es) 1983-01-01

Family

ID=22731012

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506284A Expired ES8301990A1 (es) 1980-10-17 1981-10-15 Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.

Country Status (9)

Country Link
EP (1) EP0050334B1 (es)
JP (1) JPS5795989A (es)
AT (1) ATE27701T1 (es)
DE (1) DE3176244D1 (es)
DK (1) DK458781A (es)
ES (1) ES8301990A1 (es)
GR (1) GR77296B (es)
IE (1) IE53047B1 (es)
PT (1) PT73791B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES514240A0 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
FI832619A (fi) * 1982-07-26 1984-01-27 Sandoz Ag Fluoralkylerade karbapenemderivat
ZA836966B (en) * 1982-09-28 1984-04-25 Bristol Myers Co Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1269978A (en) * 1982-09-28 1990-06-05 Choung U. Kim Carbapenem antibiotics
CH660736A5 (de) * 1983-10-03 1987-06-15 Sanraku Inc Carbapenemderivate.
US4717728A (en) * 1983-11-21 1988-01-05 Merck & Co., Inc. Cyclic amidinyl and cyclic guanidinyl thio carbapenems
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
DK189686A (da) * 1985-04-27 1986-10-28 Sankyo Co Carbapenemforbindelser og fremgangsmaade til fremstilling deraf samt middel indeholdende forbindelserne
ES2059679T3 (es) * 1988-11-08 1994-11-16 Daiichi Seiyaku Co Derivados de carbapenem.
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
AU691971B2 (en) 1994-09-16 1998-05-28 Banyu Pharmaceutical Co., Ltd. Novel carbapenem derivative
CA2199855A1 (en) * 1994-09-16 1996-03-21 Ryosuke Ushijima Novel carbapenem derivative

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170778A (da) * 1977-05-05 1979-01-15 Merck & Co Inc Fremgangsmaade til fremstilling af n-alkyl-n-iminomethyl-derivater af thienamycin
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
US4189493A (en) * 1977-12-28 1980-02-19 Merck & Co., Inc. N-heterocyclic derivatives of thienamycin
EP0008514B1 (en) * 1978-08-25 1982-01-20 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
JPS5622787A (en) * 1979-07-27 1981-03-03 Sanraku Inc Beta-lactam compound
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
JPS5649383A (en) * 1979-09-29 1981-05-02 Sanraku Inc Beta-lactam compound
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS56154484A (en) * 1980-05-01 1981-11-30 Merck & Co Inc 1-carbapenems derived from-4azetidinone and manufacture of intermediate therefor
IN155384B (es) * 1980-05-14 1985-01-19 Pfizer
JPH0471913A (ja) * 1990-07-10 1992-03-06 Nissan Motor Co Ltd 車両用サスペンション

Also Published As

Publication number Publication date
DE3176244D1 (en) 1987-07-16
PT73791A (en) 1981-11-01
ES506284A0 (es) 1983-01-01
JPS5795989A (en) 1982-06-15
EP0050334A1 (en) 1982-04-28
GR77296B (es) 1984-09-11
EP0050334B1 (en) 1987-06-10
DK458781A (da) 1982-04-18
PT73791B (en) 1983-10-14
IE53047B1 (en) 1988-05-25
ATE27701T1 (de) 1987-06-15
IE812408L (en) 1982-04-17

Similar Documents

Publication Publication Date Title
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
ES8301990A1 (es) Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
IE792027L (en) Pyrroloazetidinones
DE2966269D1 (en) 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids, process for preparing the same and pharmaceutical compositions containing the same
ES8403858A1 (es) Procedimiento para la preparacion de dipeptidos carboxialquilicos.
AU631068B2 (en) New peptide compounds, process for preparing these and pharmaceutical compositions containing them
ZA918734B (en) Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
HUT60274A (en) Process for producing thioalkyl thiocafalosporin derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ES8207538A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
ES8701174A1 (es) Un metodo de preparacion de un compuesto de tiadiazina
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
PL322594A1 (en) Derivatives of phenoxyethylamine having high afinity to the 5-ht 1a receptor, procedure of producing them, their application as drugs and pharmaceutic compounds containing them
ES8203328A1 (es) Un procedimiento para la preparacion de 6-fluordihidroxifenilalaninas.
HU214061B (hu) Eljárás fenilamino-ecetsavhidrazid származékok és az ilyen hatóanyagot tartalmazó tumornövekedést és enzimaktivitást gátló gyógyászati készítmények előállítására
ES8600762A1 (es) Un procedimiento para la preparacion de nuevos compuestos de beta-lactama.
IL70062A0 (en) Gamma-butyrolactone derivatives,their preparation and pharmaceutical compositions containing them